Clinical Trial Details

Adjuvant Lung Cancer Enrichment Mark Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)

This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Learn More

Principal Investigator(s)

Salvatore Del Prete, MD

Sponsor(s)

Alliance for Clinical Trials in Oncology

Contact

Ed Hatton, RN at 203-358-8879 or [email protected]

Location

Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-276-2695

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.